Effect of intradialytic parenteral nutrition in patients with malnutrition-inflammation complex syndrome on body weight, inflammation, serum lipids and adipocytokines: Results from a pilot study

European Journal of Clinical Nutrition

Volumn 62, Issue 6, 2008, Pages 789-795

  Joannidis, M ^a   Rauchenzauner, M ^a,c   Leiner, B ^a   Rosenkranz, A ^a   Ebenbichler, C F ^a   Laimer, M ^a   Tatarczyk, T ^a   Meusburger, E ^b   Mayer, G ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Hospital Feldkirch   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; AUSTRIA; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; INTRADIALYTIC PARENTERAL NUTRITION; KIDNEY FAILURE; LIPOPROTEIN BLOOD LEVEL; MALE; MALNUTRITION INFLAMMATION COMPLEX SYNDROME; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; PATIENT SAFETY; PILOT STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; THERAPY EFFECT; WEIGHT GAIN;

ADIPOKINES; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MALNUTRITION; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PILOT PROJECTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SERUM ALBUMIN; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 44949144023     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602777     Document Type: Article

References (45)

1. Avery-Lynch M (2006). Intradialytic parenteral nutrition in hemodialysis patients: Acute and chronic intervention. CANNT J 16, 30-33.
2. Bhagat K, Valiance P (1997). Inflammatory cytokines; impair endothelium-dependent dilatation in human veins in vivo. Circulation 96, 3042-3047.
3. Bistrian BR, Schwartz J, Istfan NW (1992). Cytokines, muscle proteolysis, and the catabolic response to infection and inflammation. Proc Soc Exp Biol Med 200, 220-223.
4. Capelli JP, Kushner H, Camiscioli TC, Chen SM, Torres MA (1994). Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 23, 808-816.
5. Chandran M, Phillips SA, Ciaraldi T, Henry RR (2003). Adiponectin: More than just another fat cell hormone? Diabetes Care 26, 2442-2450.
6. Chiang CK, Ho TI, Hsu SP, Peng YS, Pai MF, Yang SY et al. (2005). Low-density lipoprotein cholesterol: Association with mortality and hospitalization in hemodialysis patients. Blood Purif 23, 134-140.
7. Clinical practice guidelines for nutrition in chronic renal failure (2000). K/DOQI, National Kidney Foundation. Am J Kidney Dis 35 S1-S140.
8. Cofan F, Vela E, Cleries M (2006). Analysis of dyslipidemia in patients on chronic hemodialysis in Catalonia. Atherosclerosis 184, 94-102.
9. Considine RV, Sinha MK, Heiman ML, Kriauciumas A, Stephens TW, Nyce MR et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292-295.
10. Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA (2001). Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 59, 1114-1120.
11. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996). Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7, 728-736.
12. Fung F, Sherrard DJ, Gillen DL, Wong C, Kestenbatun B, Seliger S et al. (2002). Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 40, 307-314.
13. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y et al. (2000). Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 1595-1599.
14. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM (1999). Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study. Kidney Int 55, 1945-1951.
15. Kalantar-Zadeh K, Ikizler TA, Block G, Avram. MM, Kopple JD (2003a). Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 42, 864-881.
16. Kalantar-Zadeh K, Kopple JD (2001). Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38, 1343-1350.
17. Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD (2003b). Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 120. J Ren Nutr 13, 15-25.
18. Kopple JD (1978). Abnormal amino acid and protein metabolism in uremia. Kidney Int 14, 340-348.
19. Kopple JD (1997). Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J 43, 246-250.
20. Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J (2001). Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 283, 982-988.
21. Lightfoot BOCJ, Fincher ME, Mulloy LL (1994). Accurate determination of normalized protein catabolic rate (NPCR) using a nonlogarithmic Kt/V formula (Abstract). J Am Soc Nephrol 5, 496A.
22. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y et al. (1995). Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1, 1155-1161.
23. Mantzoros CS (1999). The role of leptin in human obesity and disease: A review of current evidence. Ann Intern Med 130, 671-680.
24. Marckmann P (1988). Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 29, 75-78.
25. Moller DE (2000). Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11, 212-217.
26. Mortelmans AK, Vanholder R (1999). Intradialytic parenteral nutrition in malnourished hemodialysis patients. Review of the literature. Miner Electrolyte Metab 25, 324-332.
27. Nawabi MD, Block KP, Chakrabarti MC, Buse MG (1990). Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase. J Clin Invest 85, 256-263.
28. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y et al. (1999). Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 2473-2476.
29. Owen Jr WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM (1993). The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329 1001-1006.
30. Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA (1994). Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45, 890-896.
31. Prichard SS (2003). Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol 14, S315-S320.
32. Pupim LB, Kent P, Hakim. R (1999). The potential of intradialytic parenteral nutrition: A review. Miner Electrolyte Metab 25, 317-323.
33. Rodriguez-Carmona A, Perez Fontan M, Cordido F, Garcia Falcon T, Garcia-Buela J (2000). Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. A cross-sectional study in predialysis, peritoneal dialysis and hemodialysis patients. Nephron 86, 274-280.
34. Santos NS, Draibe SA, Kamimura MA, Canziani ME, Cendoroglo M, Junior AG et al. (2003). Is serum albumin a marker of nutritional status in hemodialysis patients without evidence of inflammation? Artif Organs 27, 681-686.
35. Shoji T, Shinohara K, Hatsuda S, Kimoto E, Fukumoto S, Emoto M et al. (2005). Altered relationship between body fat and plasma adiponectin in end-stage renal disease. Metabolism 54, 330-334.
36. Siskind MS, Lien YH (1993). Effect of intradialytic parenteral nutrition on quality of life in hemodialysis patients. Int J Artif Organs 16, 599-603.
37. Steinman TI (2000). Serum albumin: Its significance in patients with ESRD. Semin Dial 13, 404-408.
38. Stenvinkel P. Heimburger O, Lonnqvist F (1997). Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 12, 1321-1325.
39. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L et al. (1999). Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55, 1899-1911.
40. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J (2000). Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Ransplant 15, 953-960.
41. Thunberg BJ, Swamy AP, Cestero RV (1981). Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 34, 2005-2012.
42. Tintut Y, Patel J, Parhami F, Demer LL (2000). Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102, 2636-2642.
43. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000). Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 148, 209-214.
44. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Warmer C (1999). Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55, 648-658.
45. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S et al. (2002). Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13, 134-141.